Stock Market News Briefs: ArQule, Blackbaud, ISTA Pharmaceuticals, Venoco, Valeant Pharmaceuticals International
Posted on January 18, 2012 at 09:26 AM EST
    Bio technology company ArQule Inc.’s (NASDAQ:ARQL) share prices gained 11.91% to close at $6.67 after the company’s experimental treatment for liver cancer reported a positive outcome in its Phase II trial     Share prices of discount carrier Sprint Airlines Inc. (SAVE) declined 5.53% after the company announced plans to sell 11 million shares in [...]

    Bio technology company ArQule Inc.’s (NASDAQ:ARQL) share prices gained 11.91% to close at $6.67 after the company’s experimental treatment for liver cancer reported a positive outcome in its Phase II trial

    Share prices of discount carrier Sprint Airlines Inc. (SAVE) declined 5.53% after the company announced plans to sell 11 million shares in a secondary offering

    Global provider of software Blackbaud Inc. (NASDAQ:BLKB) will buy fund raising … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here